{
    "clinical_study": {
        "@rank": "26814", 
        "acronym": "CURARES", 
        "arm_group": [
            {
                "arm_group_label": "Atracurium", 
                "arm_group_type": "Experimental", 
                "description": "injection of NMBA 0.5 mg/kg milligram(s)/kilogram in Intravenous bolus use"
            }, 
            {
                "arm_group_label": "ROCURONIUM", 
                "arm_group_type": "Experimental", 
                "description": "injection of NMBA 0.6 mg/kg milligram(s)/kilogram in Intravenous bolus"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "injection of placebo Injection in Intravenous bolus use"
            }
        ], 
        "brief_summary": {
            "textblock": "Phase III prospective randomised study : curare vs placebo, comparing bowel peristalsis\n      (abdominal echography) in the first minutes of after general anesthesia induction.\n\n      Primary End Point: proportion of patients with a score of motion = 0"
        }, 
        "brief_title": "Assessment Study of the Effect of NMBA on Bowel Peristalsis", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Physiopathology", 
        "detailed_description": {
            "textblock": "Primary End Point Proportion of patients with a score of motion = 0\n\n      Secondary End Point Time at which thumb adductor twitch measurement disappears (3rd\n      consecutive measure with a twitch at 0) Mean minimal twitch measurement for those patients\n      in who twitch measurement does not disappear Concordance study between twitch measurement\n      and bowel peristalsis XML File Identifier: 1vUwHz2uUXeSc7soLu1cQwRAfcM= Page 15/24\n      ultrasound score."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  elective surgery\n\n          -  scheduled oro tracheal intubation\n\n        Exclusion Criteria:\n\n        Counter indication to NMBA:\n\n          -  predicted difficult airway\n\n          -  surgical counter indication: facial or laryngeal nerve function monitoring\n\n          -  allergy to muscle relaxants neuro muscular disease Possible alteration of sensitivity\n             to muscle relaxants due to ongoing medication: ex Valproate or aminoglycoside\n             antibiotics. Predictable alteration of bowel movements or difficult abdominal\n             ultrasound:\n\n          -  scheduled abdominal surgery\n\n          -  abdominal surgery in last month\n\n          -  obesity: body mass index over 30 Full stomach or pregnancy requiring suxamethonium\n             for intubation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02004015", 
            "org_study_id": "RBM_WTR_2012-9"
        }, 
        "intervention": [
            {
                "arm_group_label": "placebo", 
                "description": "0.5 mg/kg milligram(s)/kilogram", 
                "intervention_name": "injection of placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Atracurium", 
                    "ROCURONIUM"
                ], 
                "intervention_name": "injection of NMBA", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Neuromuscular Blocking Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Analytical", 
            "Diagnostic", 
            "Anesthesia", 
            "Analgesia"
        ], 
        "lastchanged_date": "December 3, 2013", 
        "location": {
            "contact": {
                "email": "gtaylor@fo-rothschild.fr", 
                "last_name": "Guillaume Taylor", 
                "phone": "+33148036748"
            }, 
            "contact_backup": {
                "email": "lsalomon@fo-rothschild.fr", 
                "last_name": "Laurence Salomon", 
                "phone": "+33148036431"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75019"
                }, 
                "name": "Fondation Ophtalmologique Adolphe de Rothschild"
            }, 
            "investigator": {
                "last_name": "Guillaume Taylor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effect of an Induction Dose of Non Depolarizing Neuro Muscular Blocking Agents (NMBA) on Ultrasound Bowel Peristalsis.", 
        "overall_contact": {
            "email": "gtaylor@fo-rothschild.fr", 
            "last_name": "Guillaume Taylor, MD", 
            "phone": "+33148036748"
        }, 
        "overall_contact_backup": {
            "email": "lsalomon@fo-rothschild.fr", 
            "last_name": "laurence Salomon, MD, PhD", 
            "phone": "+33148036431"
        }, 
        "overall_official": {
            "affiliation": "Fondation Ophtalmologique Adolphe de Rothschild", 
            "last_name": "Guillaume Taylor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of patients with a score of motion = 0", 
            "measure": "Proportion of patients with a score of motion = 0", 
            "safety_issue": "No", 
            "time_frame": "10 minutes after NMBA or placebo injection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02004015"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Time at which thumb adductor twitch measurement disappears (3rd consecutive measure with a twitch at 0). Mean minimal twitch measurement for those patients in who twitch measurement does not disappear. Concordance study between twitch measurement and bowel peristalsis", 
            "measure": "Time at which thumb adductor twitch measurement disappears", 
            "safety_issue": "No", 
            "time_frame": "1 month after injection"
        }, 
        "source": "Fondation Ophtalmologique Adolphe de Rothschild", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fondation Ophtalmologique Adolphe de Rothschild", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}